It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

According to Novo Nordisk’s website, the price of an Ozempic pen (0.25 ... and convenient dosage (such as oral pills instead ...

It is thought to be the first death in the UK linked to the medication Mounjaro, nicknamed the ‘King Kong jab’ ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...

Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday.

She’d first heard of Wegovy, a GLP-1 made by Novo Nordisk ... she said. Brand-name GLP-1 medications come in fixed-dose pen ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

NEW YORK (AP) — The CEO of PEN America, Suzanne Nossel, is stepping down after more than a decade marked by substantial growth and recent controversy, In January, she will be heading the pro ...

The lowest dose of Novo Nordisk's (NOVOb.CO), opens new tab weight-loss drug, Wegovy, was listed as available on the U.S. health regulator's website on Wednesday. Several doses of Novo's GLP-1 ...